MDNews - Lower Hudson/Bronx

November 2015

Issue link: https://viewer.e-digitaledition.com/i/595434

Contents of this Issue

Navigation

Page 6 of 23

In October 2015, the center moved into a new space on the Nyack Hospital campus. Now known as the Madlyn Borelli Multiple Sclerosis Center at Nyack Hospital, the center is planning for further growth, including the launch of a clinical research program. An All-encompassing Treatment Destination Indications for referral to the Madlyn Borelli Multiple Sclerosis Center at Nyack Hospital include a confirmed or suspected diagnosis of multiple sclerosis or the presence of other neuroinflammatory dis- eases, such as transverse myelitis or optic neuritis — which can be presenting signs of multiple sclerosis — and neuromyelitis optica. Presenting symptoms that may warrant a referral for a multiple sclerosis evaluation include fatigue, bowel or blad- der dysfunction, paresthesias, blurred and/or double vision, and muscle weak- ness. The Center for Diagnostic Imaging at Nyack Hospital offers state-of-the-art MRI allowing patients to receive the imaging necessary to diagnose multiple sclerosis and monitor disease progression on-site. Though there is currently no cure for multiple sclerosis, the number of drugs available to slow disease progression and prevent exacerbations has expanded greatly throughout the last decade. The FDA has approved seven injectable medi- cations, three oral medications and three infusion therapies, with new drugs on the horizon. "Because we a re a f filiated w ith an academic center, we are familiar with the latest drugs on the market," "When providers refer to us, they can rest assured that their patients are getting comprehensive care and that they will receive constant communication regarding their patient's condition. In health care, there is a current push to keep patients out of the hospital, and that is only achieved when patients are thoroughly evaluated and there is a strong relationship between specialists and referring physicians." — Jennifer Reardon, CNRN, certified multiple sclerosis nurse and advanced nurse practitioner at the Madlyn Borelli Multiple Sclerosis Center at Nyack Hospital Dr. Perumal says. "Our knowledge of each medication and its potential adverse effects well equips us to find the drug that will be most effective, depending on the aggressiveness of the patient's particular disease state, and to monitor patients on treatment carefully." The infusion center at Nyack Hospital is cer t i f ie d to of fer a l l approve d intravenous medications, including Lemtrada (alemtuzumab), natalizumab, and also IVIG and IV steroids, which are used in the treatment of MS as well. Dr. Perumal and Reardon have Meetings are held regularly to collaborate on optimizing patient care and to discuss new research and developments in the field. Jennifer Reardon, CNRN, evaluates a patient's gait and balance by monitoring ambulation down a corridor as part of a complete assessment of the patient's neurological status. M D N E W S . CO M ■ MD NEWS Lower Hudson Bronx | 7

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - November 2015